NCT03276832 2025-10-28Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV MelanomaMayo ClinicPhase EARLY_PHASE1 Completed7 enrolled
NCT04883645 2025-01-28Neoadjuvant Imiquimod Immunotherapy for Oral CancerMedical University of South CarolinaPhase EARLY_PHASE1 Completed16 enrolled 10 charts
NCT05838599 2024-03-12Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis FungoidesNorthwestern UniversityPhase EARLY_PHASE1 Recruiting25 enrolled